Elevated levels of circulating tumor necrosis factor alpha in human immunodeficiency virus type 1-infected Africans living in Sweden.

Por Sönnerborg, A, Ayehunie, S, Julander, I
Publicado em 1995

Levels of hepatitis C virus (HCV) RNA in serum and their relationship to levels of immunoglobulin M and G antibodies against HCV core protein.

Por Chen, M, Sönnerborg, A, Sällberg, M
Publicado em 1995

Antigenic structure of the hepatitis C virus envelope 2 protein.

Por Zhang, Z X, Sönnerborg, A, Sällberg, M
Publicado em 1994

Site-directed serology of HIV-1 subtype B infection: relation between virus specific antibody levels and disease progression

Por BROSTRÖM, C, SÖNNERBORG, A, KIM, S, SÄLLBERG, M
Publicado em 1996

Detection of hepatitis G virus (GB virus C) RNA in human saliva.

Por Chen, M, Sönnerborg, A, Johansson, B, Sällberg, M
Publicado em 1997

HIV infection and maternal outcome of pregnancy in Mozambican women: a case-control study.

Por Bergström, S, Sonnerborg, A, Osman, N B, Libombo, A
Publicado em 1995

Antigenic structure of the complete nonstructural (NS) 2 and 5 proteins of hepatitis C virus (HCV): anti-HCV NS2 and NS5 antibody reactivities in relation to HCV serotype, presence...

Por Zhang, Z X, Chen, M, Sönnerborg, A, Sällberg, M
Publicado em 1994

Dynamic analysis of heterogeneous hepatitis C virus populations by direct solid-phase sequencing.

Por Odeberg, J, Yun, Z, Sönnerborg, A, Uhlén, M, Lundeberg, J
Publicado em 1995

Subtyping of human immunodeficiency virus type 1 strains by using antibodies specific for the third variable domain (V3) of gp120: results may be affected by divergent V3 sequences...

Por Sherefa, K, Sällberg, M, Johansson, B, Salminen, M, Sönnerborg, A
Publicado em 1997

Raised levels of tumour necrosis factor-alpha and neopterin, but not interferon-alpha, in serum of HIV-1-infected patients from Ethiopia.

Por Ayehunie, S, Sonnerborg, A, Yemane-Berhan, T, Zewdie, D W, Britton, S, Strannegard, O
Publicado em 1993

Virological Characterization of Dual HIV-1/HIV-2 Seropositivity and Infections in Southern Ghana

Por Sagoe, KWC, Mingle, JAA, Affram, RK, Britton, S, Dzokoto, A, Sonnerborg, A
Publicado em 2008

A high occurrence of late presenters and missed HIV diagnosis in clinical care in Sweden

Por Brännström, J, Svedhem, V, Yilmaz, A, Blaxhult, A, Wendahl, S, Sönnerborg, A
Publicado em 2010

The Honduran human immunodeficiency virus type 1 (HIV-1) epidemic is dominated by HIV-1 subtype B as determined by V3 domain sero- and genotyping.

Por Lara, C, Sällberg, M, Johansson, B, de Rivera, I L, Sönnerborg, A
Publicado em 1997

Antibody production against hepatitis C virus core and nonstructural 3 proteins is highly sensitive to deficits in T-cell function.

Por Ando, Y, Sönnerborg, A, Barkholt, L, Birkett, A, Ericzon, B G, Sällberg, M
Publicado em 1997

Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects

Por DE MILITO, A, ALEMAN, S, MARENZI, R, SÖNNERBORG, A, FUCHS, D, ZAZZI, M, CHIODI, F
Publicado em 2002

Antigen detection in primary HIV infection

Por von Sydow, M, Gaines, H, Sönnerborg, A, Forsgren, M, Pehrson, P O, Strannegård, Ö
Publicado em 1988

Sweden, the first country to achieve the Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) 90‐90‐90 continuum of HIV care targets

Por Gisslén, M, Svedhem, V, Lindborg, L, Flamholc, L, Norrgren, H, Wendahl, S, Axelsson, M, Sönnerborg, A
Publicado no HIV Med (2016)

Low frequency of plasma nerve-growth factor detection is associated with death of memory B lymphocytes in HIV-1 infection

Por TITANJI, K, NILSSON, A, MÖRCH, C, SAMUELSSON, A, SÖNNERBORG, A, GRUTZMEIER, S, ZAZZI, M, DE MILITO, A
Publicado em 2003

Emergence of unique recombinant forms (URFs) in Indian HIV-1 epidemic: data from nationwide clinical cohort between 2007 and 2011

Por Neogi, U, Gupta, S, Shet, A, De Costa, A, Laishram, RL, Wanchu, A, Diwan, V, Banerjea, AC, Sonnerborg, A
Publicado em 2012

Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection.

Por Wahren, B, Morfeldt-Månsson, L, Biberfeld, G, Moberg, L, Sönnerborg, A, Ljungman, P, Werner, A, Kurth, R, Gallo, R, Bolognesi, D
Publicado em 1987